[HTML][HTML] Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
H Qin, C You, F Yan, K Tan, C Xu, R Zhao… - Frontiers in …, 2022 - frontiersin.org
Cellular therapies have attracted huge research and clinical attention lately (1, 2). Natural
killer cells (NKCs) are a class of innate immune lymphoid cells (ILP) mainly derived from …
killer cells (NKCs) are a class of innate immune lymphoid cells (ILP) mainly derived from …
[引用][C] Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
H Qin, C You, F Yan, K Tan, C Xu… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
[HTML][HTML] Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
H Qin, C You, F Yan, K Tan, C Xu, R Zhao… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Cellular therapies have attracted huge research and clinical attention lately (1, 2). Natural
killer cells (NKCs) are a class of innate immune lymphoid cells (ILP) mainly derived from …
killer cells (NKCs) are a class of innate immune lymphoid cells (ILP) mainly derived from …
Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
H Qin, C You, F Yan, K Tan, C Xu, R Zhao… - Frontiers in …, 2022 - europepmc.org
Cellular therapies have attracted huge research and clinical attention lately (1, 2). Natural
killer cells (NKCs) are a class of innate immune lymphoid cells (ILP) mainly derived from …
killer cells (NKCs) are a class of innate immune lymphoid cells (ILP) mainly derived from …
[引用][C] Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper.
H Qin, C You, F Yan, K Tan, C Xu, R Zhao… - Frontiers in …, 2022 - europepmc.org